Application status and prospect of botulinum toxin A in otorhinolaryngological treatment

Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery..

Botulinum toxin A is a kind of neurotoxin produced by clostridium botulinum, and has been applied for nearly thirty years in China.The target of BTX-A is to selectively cleave the synaptosome-associated protein of 25 KD molecular mass, commonly abbreviated SNAP-25, thereby inhibiting neurotransmitter release and causing chemodenervation. The potential application of botulinum toxin A in treating the spasmodic dysphonia, hemifacial spasm, tinnitus, rhinitis has been confirmed both in clinical practice and previous studies. This paper is to review comprehensively the application status and the prospect of botulinum toxin A in otorhinolaryngological treatment.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:34

Enthalten in:

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery - 34(2020), 1 vom: 09. Jan., Seite 88-91

Sprache:

Chinesisch

Beteiligte Personen:

Xu, Y L [VerfasserIn]
Chen, J H [VerfasserIn]

Links:

Volltext

Themen:

Botulinum Toxins, Type A
Botulinum toxin A
EC 3.4.24.69
Journal Article
Otorhinolaryngological disease
Review
Treatment

Anmerkungen:

Date Completed 10.03.2020

Date Revised 02.11.2023

published: Print

Citation Status MEDLINE

doi:

10.13201/j.issn.1001-1781.2020.01.022

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM306797755